A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy
- 1 July 2001
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 50 (3), 605-614
- https://doi.org/10.1016/s0360-3016(01)01473-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Palladium-103 brachytherapy for prostate carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 2000
- The american brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysisInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Isotope selection for patients undergoing prostate brachytherapyInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine-125 interstitial implantsMedical Physics, 1998
- Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high gleason grade prostate carcinomaCancer, 1998
- A Dose–Response Study for I-125 Prostate ImplantsInternational Journal of Radiation Oncology*Biology*Physics, 1998
- The effect of prognostic factors on therapeutic outcome following transperineal prostate brachytherapySeminars in Surgical Oncology, 1997
- Biochemical disease-free survival following 125I prostate implantationInternational Journal of Radiation Oncology*Biology*Physics, 1997
- Some treatment planning considerations for 103Pd and 125I permanent interstitial implantsInternational Journal of Radiation Oncology*Biology*Physics, 1992